Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Next Generation Sequencing Market Analysis and Forecast to 2033: By TYPE (RNA Sequencing, Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing, De Novo Sequencing), TECHNOLOGY (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Other Technologies), APPLICATION (Diagnostics, Oncology, Research Applications, Clinical Investigation, Reproductive Health, Drug Discovery, HLA Typing/Immune System Monitoring, Metagenomics and Epidemiology, Consumer Genomics, Agricultural & Animal Research), END-USER (Academic & Research Institutions, Biopharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations, Diagnostic Laboratories, Forensic Labs, Agricultural Research Centers, Government & Regulatory Agencies), PRODUCT (Sequencing, Data Analysis, Sample Preparation, Target Enrichment, Others), WORKFLOW (NGS Library Preparation Kits, Semi-automated Library Preparation, Automated Library Preparation, Sequenc
... Other Technologies), APPLICATION (Diagnostics, Oncology, Research Applications, Clinical Investigation, Reproductive Health, Drug Discovery, HLA Typing/Immune System Monitoring, Metagenomics and Epidemiology, Consumer Genomics, Agricultural & Animal Research), END-USER (Academic & Research Institutions, Biopharmaceutical & Biotechnology, Hospitals ... Read More
-
Global Insomnia Therapeutics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Drug Discovery Technologies
... compound annual growth rates (CAGRs) through 2029 (forecast period 2024-2029), and regional markets of drug discovery technologies. This report highlights drug discovery technologies’ current and future market potential and gives a detailed analysis of the ... Read More
-
Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Research Report 2024(Status and Outlook)
... disease that causes nerve cells to gradually break down and die. The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half ... Read More
-
Global Biliary Tract Cancer Market (2024 Edition): Analysis By Indication (Extrahepatic Bile Duct Cancer, Intrahepatic Bile Duct Cancer), By Therapeutics, By Region, By Country: Market Insights and Forecast (2020-2030)
... a research report titled “Global Biliary Tract Cancer Market (2024 Edition)” which provides an analysis of the Global Biliary Tract Cancer industry in terms of market segmentation By Indication (Extrahepatic Bile Duct Cancer, Intrahepatic Bile ... Read More
-
Schizophrenia Therapeutics
... at a CAGR of 4.2% over the analysis period 2023-2030. Second Generation Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$7.7 Billion by the ... Read More
-
Bovine Respiratory Disease Treatment
... reach US$3.4 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Vaccines, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$1.4 ... Read More
-
Microbiome Therapeutics
... at a CAGR of 56.9% over the analysis period 2023-2030. C. Difficile Infection, one of the segments analyzed in the report, is expected to record a 53.2% CAGR and reach US$7.3 Billion by the end ... Read More
-
Parkinson's Disease Psychosis Market Insight, Epidemiology And Market Forecast - 2034
... 1,467 million which is further expected to increase by 2034. In 2023, the total diagnosed prevalence of MCI in Parkinson’s disease was highest in Germany among the EU4 and the UK, accounting for nearly 223 ... Read More
-
Complement 3 Glomerulopathy Market Insight, Epidemiology And Market Forecast - 2034
... severe anemia. It is usually diagnosed in infancy or early childhood, with symptoms like pale skin, fatigue, poor growth, and physical abnormalities such as thumb deformities or heart defects in some cases. In 2023, approximately ... Read More
-
Vitiligo Therapeutics
... at a CAGR of 4.0% over the analysis period 2023-2030. Topical Therapeutics, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Global Ophthalmic Disease Therapeutics Market (2024 Edition): Analysis By Indication (Age-related macular degeneration, Diabetic macular edema, Other retinal disorders), By Therapies, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)
... Azoth Analytics has released a research report titled “Global Ophthalmic Disease Therapeutics Market (2024 Edition)” which provides a Age-related macular degeneration analysis of the Global Ophthalmic Disease Therapeutics industry in terms of market segmentation By ... Read More
-
Gastrointestinal Therapeutics
... at a CAGR of 5.1% over the analysis period 2023-2030. Crohn`s Disease End-Use, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$19.0 Billion by the end ... Read More
-
Dilated Cardiomyopathy Therapeutics
... by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Angiotensin II Receptor Blockers (ARBs) Drug Class, one of the segments analyzed in the report, is expected to record a 4.9% CAGR ... Read More
-
Gastroparesis Drugs
... at a CAGR of 4.7% over the analysis period 2023-2030. Idiopathic Gastroparesis Drugs, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.3 Billion by the end ... Read More
-
Single-Use Bioprocessing
... at a CAGR of 20.8% over the analysis period 2023-2030. Single-Use Media Bags & Containers, one of the segments analyzed in the report, is expected to record a 22.6% CAGR and reach US$29.9 Billion by ... Read More
-
Alzheimer's Disease Market Insight, Epidemiology And Market Forecast - 2034
... 7MM is expected to increase, driven by better diagnosis and the launch of emerging therapies. DelveInsight’s analysis estimates that among the total diagnosed prevalent cases of Myotonic Dystrophy in 7MM approximately 51% of cases were ... Read More
-
Primary Sclerosing Cholangitis (PSC) - Market Insight, Epidemiology And Market Forecast - 2034
... have bones that break easily, often from little or no trauma. There are currently no US FDA or Europe-approved treatments for osteogenesis imperfecta. Treatment is directed toward preventing or controlling the symptoms. There are at ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast - 2034
... and these cases are going to increase during the forecast period (2024–2034). This increase in growth can be attributed to growing awareness, ultimately leading to an increase in the diagnosed prevalence of COPD. Analyst projected ... Read More
-
Small Molecule Drug Discovery
... reach US$58.4 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Oncology Therapeutic Are, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and ... Read More
-
Thin Film Drugs Market
... 10.95 billion in 2024 to USD 24.37 billion by 2032, exhibiting a CAGR of 10.5% during the forecast period of 2024-2032. The thin film drugs market growth was being highly impacted by the phenomenon of ... Read More
-
HIV Drugs Market
... 2024 to USD 58.24 billion by 2032, exhibiting a CAGR of 6.2% during the forecast period of 2024-2032. This led to the decline of the market because of the disruptions in the supply chain of ... Read More
-
Diabetic Macular Edema Treatment
... reach US$5.5 Billion by 2030, growing at a CAGR of 2.1% over the analysis period 2023-2030. Anti-VEGF Products, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach ... Read More
-
Lupus Therapeutics
... at a CAGR of 8.6% over the analysis period 2023-2030. Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$2.7 Billion by the end of ... Read More
-
Male Hypogonadism
... at a CAGR of 5.0% over the analysis period 2023-2030. Testosterone Replacement Therapy, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.5 Billion by the end ... Read More